ERADICATE phase 3 study results highlight the potential role of ceftobiprole in the treatment of Staphylococcus aureus bacteremia (SAB)
Late breaker presentation at IDWeek 2022 First double-blind registrational phase 3 study in Staphylococcus aureus…
Rhino Propels Federated AI into the Enterprise Tech Stack